Physician
Neurology
Dr. Curtis P. Schreiber, MD
|
|
Give Review
Doctor Curtis P. Schreiber, MD works in the field of Neurology. He graduated from Mayo Medical School. Mayo Medical School is ranked 27/42 in Research/PrimaryCare. Curtis P. Schreiber, MD is also a published doctor. He has 20 publication published. The most recent publication is: A multi-center double-blind pilot comparison of onabotulinumtoxinA and topiramate for the prophylactic treatment of chronic migraine. He accepts all Medicare patients.
Publications
- A multi-center double-blind pilot comparison of onabotulinumtoxinA and topiramate for the prophylactic treatment of Chronic migraine.
- Sinus problems as a cause of Headache refractoriness and migraine chronification.
- Diagnosis of menstrual Headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 10...
- An otolaryngology, neurology, allergy, and primary care consensus on diagnosis and treatment of sinus Headache.
- Sinus Headache, migraine, and the otolaryngologist.
- Sinus Headache: a neurology, otolaryngology, allergy, and primary care consensus on diagnosis and treatment.
- Prevalence of migraine in patients with a history of self-reported or physician-diagnosed "sinus" Headache.
- The pathophysiology of primary Headache.
- Understanding the patient with migraine: the evolution from episodic headache to chronic neurologic Disease. A proposed classification of patients with headache.
- Sinus Headache: a clinical conundrum.
- Building a migraine toolkit for patients: successful management of migraine Headache.
- Sinus Headache or migraine? Considerations in making a differential diagnosis.
- Short-term frovatriptan for the prevention of difficult-to-treat menstrual migraine attacks.
- Cosensitization of pain and psychiatric comorbidity in Chronic daily headache.
- Sumatriptan: update and review.
- A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine.
- Primary Headaches: a convergence hypothesis.
- Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
- Gelstat Migraine (sublingually administered feverfew and ginger compound) for acute treatment of migraine when administered during the mild pain phase.
Schools
Mayo Medical School
Mayo Grad School MedMayo Fndn
Procedures Preformed
- EEG (Electroencephalogram)
- EMG (Electromyography)
- Nerve Block, Somatic
- Non-Cosmetic Chemodenervation
Conditions Treated
- Alzheimer's Disease
- Ataxia
- Autonomic Disorders
- Bell's Palsy
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Education
-
Mayo School of Graduate Medical Education -
Mayo Medical School
Drug Facts
| NPI NUMBER | 1962461939 | |
| NPPES Provider LastName | SCHREIBER | |
| NPPES Provider FirstName | CURTIS | |
| NPPES Provider ZIPCode | 656133017 | |
| NPPES Provider State | MO | |
| Specialty Description | Neurology | |
| Total Claim Count | 3972.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 77.0 | |
| Percent Opioid Claims | 1.94 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1962461939 |
| Last Name Of The Provider | SCHREIBER |
| First Name Of The Provider | CURTIS |
| View All |
Similar Doctors
|
|
Dr. Elvin Hamlin, MD |